IQVIA Holdings Inc. (IQV) earnings on July 28, 2026
More IQVIA Holdings Inc. earnings
Prior outlook: Optimistic Outcome: Accurate
IQV shares surged after earnings, closing up 16% despite fears of a post-news drop.
IQV price around the earnings
242.94
Change: +13.9%
2026-07-28, 20:00 UTC
Start of the measured window
End of the measured window
213.22
224.49
235.75
247.02
213.22
July 28, 2026
- Price: green if it ends above the starting price; red if it ends below
- Start of the measured window
- End of the measured window
- Market open
- Starting price
Prior thesis
Prior outlook: Optimistic Outcome: Accurate
- Thesis published
- Results released
Strong recent trend and a strong recent record of beating earnings with analyst upgrades; high expectations near resistance create sell-the-news risk.
Context analyzed before publication
- Trend
- Trajectory scores rising 65→70 over 7 days indicates a strengthening recent trend but elevated sell-the-news risk into BMO.
Analysts
Evidence
- Analyst consensus
- Strong buy
- Consensus average (1-5)
- 1.45
- Analysts covering the stock
- 19
- Average price target
- 232
- Lowest price target
- 200
- Highest price target
- 284
- Upside to price target
- 8.8%
- Quarterly earnings growth
- 10%
- Revenue growth
- 8.4%
- Forward EPS
- 14.17
- Trailing EPS
- 8.25
- Analyst moves in the last 60 days
- 3
- Strong buy: 4
- Buy: 15
- Hold: 3
- Sell: 0
- Strong sell: 0
- Strong buy
- 4
- Buy
- 15
- Hold
- 3
- Sell
- 0
- Strong sell
- 0
- July 13, 2026 · Mizuho: Maintains rating (Outperform → Outperform)
- July 1, 2026 · Baird: Maintains rating (Outperform → Outperform)
- June 17, 2026 · Morgan Stanley: Downgrades rating (Overweight → Equal-Weight)
News and sentiment
Evidence
Sentiment
- Sentiment
- Neutral
- Mention volume
- Low
- Normalized volume
- 33%
News
Sources (2)
- Mizuho Maintains Outperform on IQVIA Holdings, Raises Price Target to $230 (opens in a new tab) — Benzinga
- Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $249 (opens in a new tab) — Benzinga
Technicals
Evidence
- Average true range (ATR)
- 2.8%
- Distance to 52-week high
- -12.7%
- 14-day change (14d)
- +2.8%
- 30-day change (31d)
- +11.5%
- 30-day relative strength
- +10.2%
- SPY change (31d)
- +1.3%
- Nearest support
- 211.52
- Nearest resistance
- 214.38
- Volume accumulation ratio (14d / 46d)
- 0.66
Trends
Evidence
- Average earnings surprise
- +1.5%
- May 5, 2026: actual EPS 2.9 vs estimate 2.82 (surprise +3.0%)
- February 5, 2026: actual EPS 3.42 vs estimate 3.4 (surprise +0.7%)
- October 28, 2025: actual EPS 3 vs estimate 2.98 (surprise +0.8%)
- July 22, 2025: actual EPS 2.81 vs estimate 2.77 (surprise +1.4%)
Expected move
- Implied move
- +2.6%
- Source
- Options chain
Reactions over its last 20 earnings
- Median move
- 3.6%
- 75th percentile move
- 6.7%
- 90th percentile move
- 10.9%
- Up / down moves
- 11 / 9
- Average up move
- +6.0%
- Average down move
- -4.3%
Monitoring and close
What IQVIA Holdings Inc. reported
- Status
- Finished
| Actual EPS | 3.15 |
|---|---|
| EPS estimate | 3.03 |
| EPS surprise | +4.0% |
| Revenue | $4,368 million |
| Revenue estimate | $4,301 million |
| Revenue surprise | +1.6% |
IQVIA reported better-than-expected Q2 earnings and raised its FY2026 guidance, leading to an optimistic outlook among investors.
Sources (15)
- IQVIA Holdings Inc (IQV) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and AI-Driven ... (opens in a new tab) — GuruFocus.com
- IQVIA Q2 Earnings Call Highlights (opens in a new tab) — MarketBeat
- IQVIA Holdings Inc. Q2 2026 Earnings Call Summary (opens in a new tab) — Moby
- This Healthcare Stock Is Today’s Best in the S&P 500 (opens in a new tab) — Barrons.com
- IQVIA Holdings Inc. (IQV) Q2 2026 Earnings Call Transcript (opens in a new tab) — SeekingAlpha
- Clinical Trials Provider Soars, Clears Buy Point On Solid Q2 Results (opens in a new tab) — Investor's Business Daily
- IQV Q2 Earnings Beat Estimates on R&D Bookings, Guidance Raised (opens in a new tab) — Zacks
- Stocks making the biggest moves midday: Boeing, Amkor, Corning, Sandisk, IQVIA & more (opens in a new tab) — CNBC
- IQVIA (NYSE:IQV): Quality Stock Surges on Q2 Earnings Beat and Raised Outlook (opens in a new tab) — ChartMill
- IQVIA Holdings (IQV) Q2 Earnings and Revenues Beat Estimates (opens in a new tab) — Zacks
- IQVIA’s (NYSE:IQV) Q2 CY2026 Sales Top Estimates, Stock Soars (opens in a new tab) — StockStory
- IQVIA beat Q2 expectations with adjusted EPS of $3.15 and revenue of $4.368 billion. — Benzinga
- IQVIA Hldgs Q2 Adj. EPS $3.15 Beats $3.03 Estimate, Sales $4.368B Beat $4.301B Estimate (opens in a new tab) — Benzinga
- IQVIA Holdings Raises FY2026 Adj EPS Guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.80 Est; Raises FY2026 Sales Guidance from $17.150B-$17.350B to $17.275B-$17.475B vs $17.286B Est (opens in a new tab) — Benzinga
- IQVIA Reports Second-Quarter 2026 Results (opens in a new tab) — Yahoo
Pre-market second reading after the results
- Verdict
- Beat expectations
Heading into the open, the figures confirm the optimistic scenario. In the 1037 past cases with a similar move, the close held that direction 96% of the time.
How the stock reacted
- Outcome
- Accurate
- Consolidated
- +13.9%
- Max favorable move (MFE)
- 16.2%
- Max adverse move (MAE)
- 0%